Abstract Submission Rules | EMIM 2027

Check submission rules carefully, before proceeding to the submission system!

Submission Period: 29 September to 12 November

Quick reminder, that…
  • The number of submissions as presenting author is limited to one (no limit on co-authorship).
  • The overall number of submissions is limited to the top scored 750.
  • You have to confirm that
    a) the work has not been published yet (at the time of the submission deadline) and
    b) was not presented at former EMIMs.
  • Always provide data (figures) to support your conclusion and results.

Submission Rules

  • all abstracts must be submitted via the online submission system
  • first time users (of the EMIM 2027 abstract system) need to create an account to enter the submission system
  • login data for earlier EMIMs or your member login are not valid for the EMIM 2027 submission system
  • make sure that your email address for the log-in is the same as for the actual submission (author email)
  • your abstract must be submitted to one of the abstract category (see below)
  • IMPORTANT! Make sure to provide data/figures to support your results and conclusion.
  • you strictly have to follow the scheme: 
    Introduction
    Methods
    Results/Discussion
    Conclusions
    Acknowledgement (optional)
    References (optional)
  • size limit: all in all 2850 characters (incl. space characters) divided into:
    Introduction: 600
    Methods: 800
    Results/Discussion: 1000
    Conclusion: 450
    + Novelty: 150
    + Impact: 150
  • you can add a maximum of two figures/pictures (jpeg, png) each with a limited size file of 2MB
  • application for the EMIM 2027 Young Investigator Award (check on eligibility criteria first!) is possible during the submission process with deadline 12 November 2026
  • you will be able to make changes on your submission until the submission deadline
  • all abstracts will be acknowledged upon receipt (subject: Abstract Transmission Report). If you do not receive an automated transmission report by email please contact the helpdesk or the ESMI office
  • notifications on acceptance and type of presentation (poster/talk) will be sent on 4 January 2027 at latest for abstracts submitted within the deadline 12 November.

Abstract Categories

  1. PHYSICS, ENGINEERING & TECHNOLOGIES
    1. PET/SPECT, Hybrid Technologies
    2. MRI & MRS Technologies
    3. MPI Technology
    4. Optical Technologies
    5. Ultrasound & Optoacoustic Technologies
    6. X-Ray Technologies
    7. Spatial Tissue Omics (incl. MSI, Genomics)
  2. PROBE CHEMISTRY & REPORTER GENES
    1. PET/SPECT, X-Ray, CT | Probes/Reporter Genes
    2. MRI | Probes/Reporter Genes
    3. MPI | Probes/Reporter Genes
    4. Optical | Probes/Reporter Genes
    5. Optoacoustics & Ultrasound | Probes/Reporter Genes
    6. Multimodal | Probes/Reporter Genes
    7. Theranostic Agents
  3. IMAGE PROCESSING, QUANTIFICATION & AI
    1. Acquisition, Reconstruction & Processing
    2. Quantification & Analysis
    3. Artificial Intelligence, Machine Learning, Data Modelling
  4. IMAGE-GUIDED THERAPY
    1. Interventional & Surgical Imaging
    2. Image-Guided Drug Delivery
    3. Theranostic Applications
  5. CARDIOVASCULAR & RESPIRATORY
    1. Cardiac Imaging
    2. Vascular Imaging
    3. Pulmonary Imaging
  6. CNS & PERIPHERAL NERVES
    1. Brain (Micro) Structure & Receptors
    2. Brain Metabolism, Function & Perfusion
    3. Neuroimaging in Disease Models
  7. ONCOLOGY
    1. Cancer Biology (incl. Metabolism) & Microenvironment
    2. Cancer Diagnosis
    3. Cancer Therapy (incl. Immunotherapy)
  8. IMMUNOLOGY, INFLAMMATION & INFECTION
    1. Immune System Dynamics & Immunopathology
    2. Infection & Tissue Immunity
  9. NAMS & IN VITRO MODELS

For 9: main category = abstract category

Technical support / Helpdesk 

For any technical enquiries in regards to the EMIM 2027 abstract submission please contact EventClass
+49 (351) 30900031
email to the helpdesk

A word on scientific level & Review process

The scientific level of submissions is traditionally very high. Scientific quality and originality of your work is the sole basis for a decision on acceptance and presentation type (oral/poster). Each abstract is reviewed by at least 12 independent reviewers in a double blind reviewing process along the following parameters:

  • Originality of Content
  • Soundness of Conclusion
  • Importance
  • Quality
  • Novelty
  • Impact